
Lecturer in Biomedical Engineering, Centre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, UK.
Oana Dobre holds a PhD in Mechanical Engineering (Tribology) from Imperial College London. After her doctoral studies, she worked as a Research Associate at the University of Manchester for two years, where she became fascinated by mechanobiological research and developed an expertise in biology to complement her extensive engineering background. From 2017 to 2022, Oana was a Research Associate at the Centre for the Cellular Microenvironment (CeMi) at the University of Glasgow. Her research focused on developing and characterizing full-length protein-based hydrogels for efficient growth factor delivery for tissue engineering applications, with a particular emphasis on bone tissue regeneration, spinal cord injuries, and vascularization. She started a Lecturer in Biomedical Engineering position at the University of Glasgow in 2022.
Her current research is focused on the development of a biomaterial platform using piezoelectric constructs for applications in regenerative medicine, particularly muscle regeneration, in vitro tissue models for drug testing, and new therapies using additive manufacturing techniques. Oana’s work combines a strong engineering foundation with deep knowledge of stem cell biology and extracellular matrix dynamics.
Oana Dobre
Centre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, United Kingdom.
Small-diameter vascular grafts (<6 mm) remain one of the most persistent unsolved challenges in cardiovascular surgery. Existing synthetic conduits continue to fail through mechanisms of thrombosis, compliance mismatch, and inability to remodel — and to date, no tissue-engineered vascular graft has demonstrated consistent clinical success. Biodegradable, piezoelectric biomaterials such as poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) offer a promising alternative, combining favourable degradation kinetics with mechano-electrical cues that may support vascular cell behaviour.
This presentation reports on the design and characterisation of electrospun PHBV scaffolds fabricated as multilayer tubular constructs of increasing wall thickness. Fibre morphology was assessed by scanning electron microscopy, and mechanical performance was evaluated through uniaxial tensile and burst pressure testing. A non-piezoelectric poly(ε-caprolactone) (PCL) scaffold with matched fibre diameter served as a negative control. Endothelial compatibility was assessed using human umbilical vein endothelial cells (HUVECs), with cell adhesion and viability evaluated at defined time points.
Increasing scaffold wall thickness produced reproducible gains in tensile stiffness and ultimate tensile strength that exceeded minimum clinical benchmarks, and substantially improved pressure-bearing capacity. However, burst pressures remained below native arterial values, constrained by leakage at layer interfaces rather than structural failure of the fibrous network — a finding that points toward opportunities for interfacial refinement in future multilayer architectures. While PHBV supported HUVEC adhesion and survival, a confluent endothelial monolayer was not achieved under the conditions tested, underscoring the need for targeted surface functionalisation strategies.
Together, these findings establish electrospun PHBV as a promising platform for small-diameter vascular graft development, demonstrate the central role of multilayer scaffold design in achieving clinically relevant mechanical properties, and delineate the mechanical and biological challenges that must be resolved on the path to a functional, implantable construct. Future work will focus on optimising layer bonding to improve burst performance, and on bio-functionalisation strategies to promote endothelialisation and long-term patency.
BiomMedD' 2026
All rights reserved © copyright by biommedd.ro